KOPRAN LTD Fair Value
KOPRAN · Healthcare · Current price ₹207.46
| Method | Fair value | Status |
|---|---|---|
| Residual income | ₹101 | 5% ROE fading to 12% over ~3 yrs, on ₹110 book |
| Relative P/E | ₹188 | EPS × 35.2 peer-median P/E |
| Graham floor | ₹115 | Conservative floor: √(22.5 × EPS × book value/share) |
| Analyst target | — | No analyst coverage |
Is KOPRAN LTD undervalued?
DocStoX estimates the fair value of KOPRAN LTD at ₹128 per share, versus the current market price of ₹207. That puts the stock about -38.5% above our fair-value estimate, which we read as "Avoid". Our confidence in this estimate is low.
How this fair value is calculated
This estimate blends 3 independent methods: Residual income (₹101), Relative P/E (₹188), Graham floor (₹115). We weight each by its reliability and skip any method whose inputs look untrustworthy — "no DCF beats a wrong DCF". This is the same deterministic engine that powers DocStoX stock pages; there is no guesswork or AI-generated number here.
Bear, base and bull scenarios
Our scenarios span ₹101 (bear) to ₹128 (base) to ₹188 (bull). A margin of safety means buying meaningfully below the base case — the wider the gap, the more room for error in the assumptions.
More on KOPRAN LTD
DocStoX estimates are generated by a deterministic valuation engine from reported financials — for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.